An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...

Anixa is a clinical stage biotech company, which develops a novel type of CAR-T cell therapy for the treatment of termly ill ovarian cancer patients and separately, a vaccine for the treatment and ...

A small group of women with advanced breast cancer received a vaccine via a clinical trial more than 20 years ago. Today, they're all still alive. Scientists say that kind of long-term survival is ...

Scientists are exploring how COVID-19 mRNA vaccines could ignite immune responses against cancer, offering a new path for cancer therapy. Based on this finding, we hypothesized that mRNA vaccines ...

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival periods. For patients with some of the deadliest cancers, getting a COVID shot ...

Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS/NRAS/BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer A total of 40.0% of patients received molecular ...

Moderna surged on reports of talks with a large biopharma for a potential partnership or buyout, despite trading at multi-year lows. MRNA's promising cancer vaccine data and surprising findings on ...